Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stearidonic acid is an omega-3 polyunsaturated fatty acid (PUFA) with the chemical formula C18H28O2. It is found in certain plant oils (notably from the Boraginaceae family such as echium oil) and some fish oils. Stearidonic acid serves as a metabolic precursor to eicosapentaenoic acid (EPA), a long-chain n−3 PUFA associated with cardiovascular and anti-inflammatory benefits[5][7][10]. Unlike alpha-linolenic acid (ALA), which is poorly converted to EPA in humans, stearidonic acid is more efficiently converted to EPA[3][9]. Mechanistically, it exerts anti-inflammatory effects by downregulating inducible nitric oxide synthase (iNOS), suppressing nuclear factor κB (NFκB) activation and mitogen activated protein kinase pathways in immune cells[7]. Supplementation increases red blood cell membrane EPA content and modulates oxylipin profiles more potently than ALA[3][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on stearidonic acid.